Contacting Glenview, a significant shareholder, has proven to be productive as CVS Health Corporation's board of directors has added four new members.

Following "productive contact" with activist investor Glenview Capital Management, American pharmacy retailer CVS Health Corporation (CVS.US) has added four new members to its board of directors. CVS Health Corporation's Executive Chairman, Roger Farah, stated: "In our discussions with the leadership of Glenview, we all agree that we can create greater value for all stakeholders, including our customers, consumers, colleagues, and shareholders, through the integration of our businesses." It is reported that Glenview purchased 2.8 million shares of CVS Health Corporation in the third quarter, increasing its stake in the company by 31%. The new board members include Leslie Norwalk, Guy Sansone, Doug Shulman, and Glenview CEO Larry Robbins. Leslie Norwalk will join the health services committee, Guy Sansone will join the audit committee, and Doug Shulman will join the management planning and development committee. With the addition of these four new members, the CVS Health Corporation board now consists of 16 members. The financial report released by CVS Health Corporation earlier this month showed that the company's third-quarter revenue increased by 6.3% year-over-year to $95.4 billion, surpassing market expectations by $2.7 billion. This was due to strong performance in its pharmacy and consumer health, as well as its healthcare benefits segments. The pharmacy and consumer health division had revenue of $32.4 billion, a growth of about 12% year-over-year, while the healthcare benefits segment of Aetna achieved $33 billion in revenue, a growth of around 26% year-over-year. As of the time of writing, CVS Health Corporation's stock in the US was up over 2% in pre-market trading on Monday.